Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 11 - 10 sector : Health technology save search
Iterum Therapeutics Reports Third Quarter 2022 Financial Results
Published: 2022-11-10 (Crawled : 14:20) - globenewswire.com
ITRM | $1.58 10.06% 36K
|
Health Technology
|
| O: -2.46%
H: 7.19%
C: 2.88%
therapeutics financial results
Nabriva Therapeutics Pivoting Strategic Focus Reports Third Quarter Financial Results and Provides Corporate Update
Published: 2022-11-10 (Crawled : 14:20) - globenewswire.com
NBRV | $1.42 1.39% 720K
|
Health Technology
|
| O: 0.91%
H: 7.27%
C: 5.0%
update therapeutics financial results
Webinar - Dr Erika Spaeth to interview A/Prof Charles Siles on risk assessment tests for serious disease
Published: 2022-11-10 (Crawled : 14:20) - globenewswire.com
GENE | News 0 d | $2.26 -4.64% -4.87% 18K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -0.45%
disease risk
Aclaris Therapeutics to Participate in Two November Healthcare Investor Conferences
Published: 2022-11-10 (Crawled : 05:00) - globenewswire.com
ACRS | $1.225 0.41% 0.41% 640K
|
Health Technology
|
| O: 0.12%
H: 1.71%
C: 0.12%
therapeutics
T2 Biosystems Announces Amendment and Extension of CRG Term Loan Agreement
Published: 2022-11-10 (Crawled : 14:00) - globenewswire.com
TTOO A | $2.725 -13.77% -15.96% 350K
|
Health Technology
|
| O: -1.08%
H: 3.83%
C: 3.83%
extension agreement
T2 Biosystems Announces Third Quarter 2022 Financial Results
Published: 2022-11-10 (Crawled : 14:00) - globenewswire.com
TTOO A | $2.725 -13.77% -15.96% 350K
|
Health Technology
|
| O: -1.08%
H: 3.83%
C: 3.83%
financial results
GENFIT Reports Third Quarter 2022 Financial Information
Published: 2022-11-10 (Crawled : 15:20) - globenewswire.com
GNFT | $3.44 -6.01% -6.4% 2.2K
|
Health Technology
|
| O: 2.03%
H: 2.23%
C: 2.23%
financial
Reata Pharmaceuticals Announces Participation in the Guggenheim 2022 Immunology and Neurology Conference and the Stifel 2022 Healthcare Conference
Published: 2022-11-10 (Crawled : 00:00) - biospace.com/
RETA | $172.36 0.02% 0.03% 0
|
Health Technology
|
| O: 4.31%
H: 1.2%
C: -5.49%
pharmaceuticals conference immunology
Vistagen Reports Second Quarter Financial Results and Provides Corporate Update
Published: 2022-11-10 (Crawled : 00:00) - biospace.com/
VTGN | $4.83 1.05% 1.04% 190K
|
Health Technology
|
| O: 7.73%
H: 7.17%
C: 7.17%
financial update results
Atreca Reports Third Quarter 2022 Financial Results and Provides Pipeline Update
Published: 2022-11-10 (Crawled : 00:00) - biospace.com/
BCEL P | $0.085 0.0% 670K
|
Health Technology
|
| O: 3.57%
H: 3.45%
C: -2.07%
financial update results
Quanterix to Participate in the Canaccord MedTech, Diagnostics and Digital Health & Services Forum
Published: 2022-11-10 (Crawled : 00:00) - biospace.com/
QTRX | $16.085 -1.32% -1.34% 410K
|
Health Technology
|
| O: 7.83%
H: 15.41%
C: 15.01%
services health diagnostics
Tyra Biosciences to Present at Upcoming Investor Conferences
Published: 2022-11-10 (Crawled : 00:00) - biospace.com/
TYRA | $16.355 5.52% 5.23% 150K
|
Health Technology
|
| O: 3.61%
H: 4.19%
C: -0.52%
Oncocyte Reports Third Quarter 2022 Financial Results
Published: 2022-11-10 (Crawled : 00:00) - biospace.com/
OCX | News | $2.5 -0.4% -0.4% 23K
|
Health Technology
|
| O: 5.02%
H: 1.56%
C: -4.73%
financial results
Spectrum Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update
Published: 2022-11-10 (Crawled : 00:00) - biospace.com/
SPPI | $1.03 -0.97% 0
|
Health Technology
|
| O: 5.57%
H: 9.88%
C: 7.49%
pharmaceuticals financial update results
Pulse Biosciences Reports Third Quarter 2022 Financial Results
Published: 2022-11-10 (Crawled : 00:00) - biospace.com/
PLSE | $6.86 0.15% 0.15% 120K
|
Health Technology
|
| O: -4.89%
H: 20.57%
C: 18.86%
financial results
Savara Reports Third Quarter 2022 Financial Results and Provides Business Update
Published: 2022-11-10 (Crawled : 00:00) - biospace.com/
SVRA | $4.675 -0.53% -0.53% 500K
|
Health Technology
|
| O: -0.9%
H: 5.45%
C: 3.64%
financial update results
Lineage Cell Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update
Published: 2022-11-10 (Crawled : 00:00) - biospace.com/
LCTX | $1.14 0.0% 330K
|
Health Technology
|
| O: 1.6%
H: 6.3%
C: 4.72%
therapeutics financial update results
Avenue Therapeutics Reports Third Quarter 2022 Financial Results and Recent Corporate Highlights
Published: 2022-11-10 (Crawled : 00:00) - biospace.com/
AZNCF | News | $138.73 -4.19% 3.7K
|
Health Technology
|
| O: 6.22%
H: 3.13%
C: -0.56%
FBIO | $1.79 2.29% 2.23% 190K
|
Health Technology
|
| O: 0.17%
H: 6.48%
C: -1.81%
ATXI | $0.1301 1.66% 280K
|
Health Technology
|
| O: -10.64%
H: 30.29%
C: 25.6%
AZN | News | $70.85 1.03% 1.02% 5.6M
|
Health Technology
|
| O: 7.08%
H: 0.84%
C: -0.43%
therapeutics financial results
AgeX Therapeutics Reports Third Quarter 2022 Financial Results
Published: 2022-11-10 (Crawled : 00:00) - biospace.com/
AGE A | $11.1 0.0% 3.8K
|
Health Technology
|
| O: -4.88%
H: 1.01%
C: -6.48%
therapeutics financial results
Poseida Therapeutics Provides Updates and Financial Results for the Third Quarter of 2022
Published: 2022-11-10 (Crawled : 00:00) - biospace.com/
PSTX | $2.15 -0.23% -0.23% 420K
|
Health Technology
|
| O: 4.18%
H: 3.56%
C: 0.22%
therapeutics financial
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.